New candidate therapeutic agents for endometrial cancer: Potential for clinical practice (Review)

By Umene Kiyoko   Banno Kouji   Kisu Iori   Yanokura Megumi   Nogami Yuya   Tsuji Kosuke   Masuda Kenta   Ueki Arisa   Kobayashi Yusuke   Yamagami Wataru   Tominaga Eiichiro   Susumu Nobuyuki   Aoki Daisuke  

Oncology Reports, Vol. 29, Iss. 3, 2013-03 ,pp. : 855-860

Spandidos Publications

Access to resources Recommend Favorite

Emerging biomarkers of prostate cancer (Review)

By Martin Sarah K.   Vaughan Taylor B.   Atkinson Timothy   Zhu Haining   Kyprianou Natasha  

Oncology Reports, Vol. 28, Iss. 2, 2012-08 ,pp. : 409-417

Spandidos Publications

Access to resources Recommend Favorite

Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review)

By  

International Journal of Oncology, Vol. 44, Iss. 6, 2014-01 ,pp. : 1799-1805

Spandidos Publications

Access to resources Recommend Favorite

Clinical Value of Intraoperative Gross Examination in Endometrial Cancer

By Franchi M.   Ghezzi F.   Melpignano M.   Cherchi P.L.   Scarabelli C.   Apolloni C.   Zanaboni F.  

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 357-361

Elsevier

Access to resources Recommend Favorite

Expression and clinical significance of FXYD3 in endometrial cancer

By                    

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 517-522

Spandidos Publications

Access to resources Recommend Favorite